PH19393A - 1,3-dithiolan-2-yl(1,3-dithian-2-yl)derivatives - Google Patents

1,3-dithiolan-2-yl(1,3-dithian-2-yl)derivatives

Info

Publication number
PH19393A
PH19393A PH20012A PH20012A PH19393A PH 19393 A PH19393 A PH 19393A PH 20012 A PH20012 A PH 20012A PH 20012 A PH20012 A PH 20012A PH 19393 A PH19393 A PH 19393A
Authority
PH
Philippines
Prior art keywords
dithiolan
dithian
derivatives
Prior art date
Application number
PH20012A
Other languages
English (en)
Inventor
Henri Dr Ramuz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PH19393A publication Critical patent/PH19393A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/06—Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08—Six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PH20012A 1973-12-21 1974-07-19 1,3-dithiolan-2-yl(1,3-dithian-2-yl)derivatives PH19393A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1803073A CH611614A5 (en) 1973-12-21 1973-12-21 Process for the preparation of heterocyclic compounds

Publications (1)

Publication Number Publication Date
PH19393A true PH19393A (en) 1986-04-07

Family

ID=4429892

Family Applications (3)

Application Number Title Priority Date Filing Date
PH20012A PH19393A (en) 1973-12-21 1974-07-19 1,3-dithiolan-2-yl(1,3-dithian-2-yl)derivatives
PH16639A PH13326A (en) 1973-12-21 1974-12-17 1,3-dithiolan-2-yl(1,3-dithian-2-yl)alkylamide derivatives and pharmaceutical composition thereof
PH20013A PH13396A (en) 1973-12-21 1977-07-19 Substituted alkyl,phenone compound derivative and process of preparation thereof

Family Applications After (2)

Application Number Title Priority Date Filing Date
PH16639A PH13326A (en) 1973-12-21 1974-12-17 1,3-dithiolan-2-yl(1,3-dithian-2-yl)alkylamide derivatives and pharmaceutical composition thereof
PH20013A PH13396A (en) 1973-12-21 1977-07-19 Substituted alkyl,phenone compound derivative and process of preparation thereof

Country Status (24)

Country Link
JP (1) JPS595594B2 (sv)
AT (5) AT344693B (sv)
AU (1) AU511714B2 (sv)
BE (1) BE823625A (sv)
CA (4) CA1057295A (sv)
CH (3) CH611614A5 (sv)
DD (1) DD116829A5 (sv)
DE (2) DE2463173C2 (sv)
DK (1) DK148323C (sv)
ES (5) ES433172A1 (sv)
FI (1) FI67216C (sv)
FR (1) FR2255064B1 (sv)
GB (3) GB1489087A (sv)
HK (1) HK43380A (sv)
HU (1) HU170429B (sv)
IE (1) IE40788B1 (sv)
IL (3) IL46146A (sv)
LU (1) LU71530A1 (sv)
NL (1) NL158496B (sv)
NO (1) NO142669C (sv)
PH (3) PH19393A (sv)
SE (2) SE415763B (sv)
YU (1) YU39311B (sv)
ZA (1) ZA747526B (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2515173A1 (fr) * 1981-10-28 1983-04-29 Delalande Sa Nouveaux derives du benzaldehyde 3-4-diethere et leur procede de preparation
JPS60142297U (ja) * 1984-02-29 1985-09-20 株式会社豊田自動織機製作所 フオ−クリフトにおける旋回型運転席の回転装置
JPS62171328U (sv) * 1986-04-23 1987-10-30
DE3642331A1 (de) * 1986-12-11 1988-06-23 Basf Ag Basisch substituierte phenylacetonitrile, ihre herstellung und diese enthaltende arzneimittel
US5434179A (en) * 1989-06-06 1995-07-18 Takeda Chemical Industries, Ltd. Method for improving brain function using cholinesterase-inhibiting aminoketone compounds
AU2002367425B2 (en) 2001-12-28 2006-03-09 Takeda Pharmaceutical Company Limited Preventives/remedies for urinary disturbance
WO2010006103A1 (en) * 2008-07-10 2010-01-14 Ore Pharmaceuticals Inc. Method for enhancing cognition or inhibiting cognitive decline

Also Published As

Publication number Publication date
IL46146A0 (en) 1975-03-13
ATA1022674A (de) 1977-12-15
AT344693B (de) 1978-08-10
AT350053B (de) 1979-05-10
FI352774A (sv) 1975-06-22
ES451135A1 (es) 1977-08-16
ES433172A1 (es) 1977-04-16
ES451136A1 (es) 1977-10-01
IL46146A (en) 1980-09-16
CA1079290A (en) 1980-06-10
IE40788L (en) 1975-06-21
GB1489088A (en) 1977-10-19
HK43380A (en) 1980-08-22
DE2460593A1 (de) 1975-07-03
GB1489087A (en) 1977-10-19
DK148323C (da) 1986-03-03
CA1057295A (en) 1979-06-26
AT349012B (de) 1979-03-12
DE2463173C2 (de) 1987-01-29
ZA747526B (en) 1975-12-31
NO744615L (sv) 1975-07-21
PH13396A (en) 1980-03-28
CH611614A5 (en) 1979-06-15
FR2255064B1 (sv) 1978-03-24
BE823625A (fr) 1975-06-20
CA1086320A (en) 1980-09-23
NO142669B (no) 1980-06-16
NO142669C (no) 1980-09-24
ATA38778A (de) 1978-08-15
AU7600874A (en) 1976-06-03
DE2460593C3 (de) 1979-09-13
FI67216B (fi) 1984-10-31
IE40788B1 (en) 1979-08-15
IL52844A0 (en) 1977-10-31
ATA38978A (de) 1978-10-15
CA1072966A (en) 1980-03-04
JPS5095267A (sv) 1975-07-29
FI67216C (fi) 1985-02-11
DK148323B (da) 1985-06-10
PH13326A (en) 1980-03-13
HU170429B (sv) 1977-06-28
AU3224278A (en) 1978-05-25
NL7416507A (nl) 1975-06-24
ATA38878A (de) 1978-08-15
ES451137A1 (es) 1977-08-16
DD116829A5 (sv) 1975-12-12
AT349014B (de) 1979-03-12
YU336874A (en) 1982-05-31
FR2255064A1 (sv) 1975-07-18
SE434746B (sv) 1984-08-13
YU39311B (en) 1984-10-31
AT349013B (de) 1979-03-12
ATA39178A (de) 1978-08-15
CH620920A5 (en) 1980-12-31
DE2460593B2 (de) 1979-01-18
SE7416086L (sv) 1975-06-23
SE415763B (sv) 1980-10-27
NL158496B (nl) 1978-11-15
GB1489086A (en) 1977-10-19
ES451134A1 (es) 1977-08-16
IL52843A0 (en) 1977-10-31
LU71530A1 (sv) 1976-11-11
AU511714B2 (en) 1980-09-04
DK668174A (sv) 1975-08-25
JPS595594B2 (ja) 1984-02-06
CH620921A5 (en) 1980-12-31

Similar Documents

Publication Publication Date Title
IL53485A0 (en) 2,3-dioxypiperazine derivatives
IL45644A (en) 3-alkyl-1,9-dihydroxyhexa-hydrodibenzo(b,d)pyran derivatives
CA1026760A (en) 3,4-dihydro-2h-naphthalin-1-one-5-oxypropyl-piperazine derivatives
PH19393A (en) 1,3-dithiolan-2-yl(1,3-dithian-2-yl)derivatives
EG11557A (en) N,n dialkylamino-carbanrate substituted oxy-pyridine derivatives used as insecticides
PH13669A (en) 6-nor-6-isopropyl-9,10-dihydro-2'beta-methyl-5'alpha-benzyl-ergopetine
GB1484291A (en) 1,3-benzo-dioxole derivatives
IL44613A (en) 3,20-dioxo-pregn-4-enoic acid derivatives
CA1025448A (en) 1,3-benzodioxole derivatives
GB1487457A (en) 5,7-dihydroxy-tetraisoquinoline derivatives
KE2924A (en) 2,3-dioyopiperazine derivatives
IL44783A0 (en) Novel 1,2,3-triazole derivatives
IE40060L (en) 1,5- and 1,8-dinitroanthraquinones
CA1029726A (en) 1,8-naphthyridine-3-carboxamidetetrazolyl derivatives
CA1035359A (en) 1-substituted-6,7-disubstituted-1,2,3,4-tetrahydroisoquinoline derivatives
CA1022169A (en) 4"-0-sulfonyl erythromycin-9-0-oxime derivatives
AU7683474A (en) Substituted 4,4#@-dicyclohexylmethane derivatives
AU503626B2 (en) Substituted 1, 5-diphenyl-3-formazancarbonitriles
CA1018157A (en) 8,8'-dioxo-6,6'-azopurine
ZA747367B (en) 3,3a-dihydro-2h,9h-isoxazolo(3,2-b) (1,3) benzoxazin-9-ones
PH11939A (en) 5,6-dibenzyloxy-2-aminotetralol derivatives
AU507862B2 (en) Novel 2,3-dioxopiperazine derivatives
AU490726B2 (en) 1, 3-dithiolan-2-yl alkylamine derivatives
PH15173A (en) "2,2-dihydro-1h, 1,4-benzodiazephine derivatives
AU492554B2 (en) 6-alkyl-9,10-dihydro-2' b-methyl-5'-benzyl-ergopeptide derivatives